Aberrant luminal progenitors as the candidate target population for basal tumor development in BRCA1 mutation carriers

Cited by (1,001)

Items 301–400 of 1,001

1. DNA Repair and Therapeutic Strategies in Cancer Stem Cells
   Matthew S. Gillespie, Ciara M. Ward, Clare C. Davies · 2023 · Cancers
2. P-cadherin role in normal breast development and cancer
   André Albergaria, Ana Sofia Ribeiro, André-Filipe Vieira, Bárbara Sousa, Ana Rita Nobre, Raquel Seruca, Fernando Carlos Schmitt, Joana Paredes · 2011 · The International Journal of Developmental Biology
3. BRCA1 and GATA3 corepress FOXC1 to inhibit the pathogenesis of basal-like breast cancers
   D Tkocz, Nyree Crawford, Niamh E. Buckley, Fred B. Berry, Richard D. Kennedy, Julia J. Gorski, Denis Paul Harkin, Paul B. Mullan · 2011 · Oncogene
4. Integrin αvβ3 Drives Slug Activation and Stemness in the Pregnant and Neoplastic Mammary Gland
   Jay S. Desgrosellier, Jacqueline Lesperance, Laetitia Seguin, Maricel C. Gozo, Shumei Kato, Aleksandra Franovic, Mayra Yebra, Sanford J. Shattil, David A. Cheresh · 2014 · Developmental Cell
5. Estrogen receptor positive breast cancers in BRCA1 mutation carriers: clinical risk factors and pathologic features
   Nadine Tung, Yihong Wang, Laura C. Collins, Jennifer Kaplan, Hailun Li, Rebecca Sue Gelman, Amy H. Comander, Bridget M. Gallagher, Katharina Fetten, Karen J. Krag et al. · 2010 · Breast Cancer Research
6. A novel blueprint for ‘top down’ differentiation defines the cervical squamocolumnar junction during development, reproductive life, and neoplasia
   Michael F. Herfs, Sara O. Vargas, Yusuke Yamamoto, Brooke E. Howitt, Marisa R. Nucci, Jason L. Hornick, Frank McKeon, Wa Xian, Christopher P. Crum · 2012 · The Journal of Pathology
7. Adult Thymus Contains FoxN1− Epithelial Stem Cells that Are Bipotent for Medullary and Cortical Thymic Epithelial Lineages
   Ahmet Uçar, Olga Ucar, Paula Klug, Sonja Matt, Fabian Brunk, Thomas G. Hofmann, Bruno Kyewski · 2014 · Immunity
8. NDY1/KDM2B Functions as a Master Regulator of Polycomb Complexes and Controls Self-Renewal of Breast Cancer Stem Cells
   Filippos Kottakis, Parthena F. Foltopoulou, Ioannis Sanidas, Patricia J. Keller, Ania Wronski, Benjamin T. Dake, Scott A. Ezell, Zhu Shen, Stephen P. Naber, Philip W. Hinds et al. · 2014 · Cancer Research
9. Profiling of normal and malignant breast tissue show CD44high/CD24lowphenotype as a predominant stem/progenitor marker when used in combination with Ep-CAM/CD49f markers
   Hazem Ghebeh, Ghida Majed Sleiman, Pulicat Subramanian Manogaran, Amer Al‐Mazrou, Eman Barhoush, Falah Almohanna, Asma M. Tulbah, Khalid Al-Faqeeh, Chaker N. Adra · 2013 · BMC Cancer
10. Identification of Lineage Relationships and Novel Markers of Blood and Skin Human Dendritic Cells
    Andrew Nicholas Harman, Christopher R. Bye, Najla Nasr, Kerrie J. Sandgren, Min Kim, Sarah K. Mercier, Rachel Anne Botting, Sharon R. Lewin, Anthony Lawrence Cunningham, Paul U. Cameron · 2012 · The Journal of Immunology
11. Enhancer-Mediated Oncogenic Function of the Menin Tumor Suppressor in Breast Cancer
    Koen M.A. Dreijerink, Anna C. Groner, Erica S.M. Vos, Alba Font‐Tello, Lei Gu, David Chi, Jaime M. Reyes, Jennifer Cook, Elgene Lim, Charles Y. Lin et al. · 2017 · Cell Reports
12. The crossroads of breast cancer progression: insights into the modulation of major signaling pathways
    Fernando Janczur Velloso, Arthur Filipini Rodrigues Bianco, Jéssica Oliveira Farias, Nadia Torres, Pault Y. M. Ferruzo, Valesca Anschau, Henrique César Jesus-Ferreira, Ted Chang, Mari Cleide Sogayar, Luiz Fernando Zerbini et al. · 2017 · OncoTargets and Therapy
13. Aldehyde Dehydrogenase Activity Is a Biomarker of Primitive Normal Human Mammary Luminal Cells
    Peter D. Eirew, Nagarajan Kannan, David J. H. F. Knapp, François Vaillant, Joanne T. Emerman, Geoffrey John Lindeman, Jane E. Visvader, Connie J. Eaves · 2011 · Stem Cells
14. The mammary myoepithelial cell
    Mejdi Moumen, Aurélie Chiche, Stéphanie Cagnet, Valérie Petit, Karine Raymond, Marisa M. Faraldo, Marie‐Ange Deugnier, Marina A. Glukhova · 2011 · The International Journal of Developmental Biology
15. Stem cells in cancer: instigators and propagators?
    Malcolm Ronald Alison, Shahriar Islam, Nicholas A. Wright · 2010 · Journal of Cell Science
16. The CD10 Enzyme Is a Key Player to Identify and Regulate Human Mammary Stem Cells
    Élodie Bachelard-Cascales, Marion Chapellier, E. Delay, Gaëtan Pochon, Thibault Voeltzel, Alain Puisieux, Claude Caron de Fromentel, Véronique Maguer‐Satta · 2010 · Stem Cells
17. The Cellular Origin and Evolution of Breast Cancer
    Mei Zhang, Adrian V. Lee, Jeffrey M. Rosen · 2017 · Cold Spring Harbor Perspectives in Medicine
18. Developmental signaling pathways regulating mammary stem cells and contributing to the etiology of triple-negative breast cancer
    María Cristina Rangel, Daniel C. Bertolette, Nadia Pereira de Castro, Małgorzata Klauzińska, Frank F. Cuttitta, David S. Salomon · 2016 · Breast Cancer Research and Treatment
19. Breast cancers, mammary stem cells, and cancer stem cells, characteristics, and hypotheses
    Sébastien Taurin, Haifa Alkhalifa · 2020 · Neoplasia
20. Age-Related Dysfunction in Mechanotransduction Impairs Differentiation of Human Mammary Epithelial Progenitors
    Fanny A. Pelissier, James C. Garbe, Badriprasad Ananthanarayanan, Masaru Miyano, Chun‐Han Lin, Tiina A. Jokela, Sanjay Kumar, Martha R. Stampfer, James B. Lorens, Mark A. LaBarge · 2014 · Cell Reports
21. Rare somatic cells from human breast tissue exhibit extensive lineage plasticity
    S. Roy, P. Gascard, N. Dumont, Jian-Xin Zhao, D. Pan, Sarah Petrie, Marta Margeta, T. Tlsty · 2013 · Proceedings of the National Academy of Sciences of the United States of America
22. Time-resolved single-cell analysis of Brca1 associated mammary tumourigenesis reveals aberrant differentiation of luminal progenitors
    Karsten Bach, Sara Pensa, Marija Zarocsinceva, Katarzyna Kania, Julie Stockis, Silvain Pinaud, Kyren A. Lazarus, Mona Shehata, Bruno M. Simões, Alice Greenhalgh et al. · 2021 · Nature Communications
23. Prostate Luminal Progenitor Cells in Development and Cancer
    Dingxiao Zhang, Shuhong Zhao, Xinyun Li, Jason S. Kirk, Dean G. Tang · 2018 · Trends in cancer
24. 90 YEARS OF PROGESTERONE: Progesterone and progesterone receptors in breast cancer: past, present, future
    Kathryn B. Horwitz, Carol A. Sartorius · 2020 · Journal of Molecular Endocrinology
25. Evolutionary histories of breast cancer and related clones
    Tomomi Nishimura, Nobuyuki Kakiuchi, Kenichi Yoshida, Takaki Sakurai, Tatsuki R. Kataoka, Eiji Kondoh, Yoshitsugu Chigusa, Masahiko Kawai, Morio Sawada, Takuya Inoue et al. · 2023 · Nature
26. Molecular Phenotypes in Triple Negative Breast Cancer from African American Patients Suggest Targets for Therapy
    Robert M. Lindner, Catherine A.W. Sullivan, Onyinye Offor, Kimberly Lezon-Geyda, Kyle Halligan, Neal A. Fischbach, Mansi Shah, Veerle Bossuyt, Vincent Schulz, David P. Tuck et al. · 2013 · PLoS ONE
27. New Opportunities and Challenges to Defeat Cancer Stem Cells
    Erika K. Ramos, Andrew Daniel Hoffmann, Stanton L. Gerson, Huiping Liu · 2017 · Trends in cancer
28. Breast Cancer in Adolescents and Young Adults: A Review With a Focus on Biology
    J. R. Tichy, Elgene Lim, Carey K. Anders · 2013 · Journal of the National Comprehensive Cancer Network
29. Control of Breast Cancer Growth and Initiation by the Stem Cell–Associated Transcription Factor TCF3
    Michal Slyper, Amit Shahar, Anat Bar-Ziv, Roy Zvi Granit, Tamar Hamburger, Bella Maly, Tamar Peretz, Ittai Ben‐Porath · 2012 · Cancer Research
30. Dissecting the stem cell niche with organoid models: an engineering-based approach
    Lyndsay M. Murrow, Robert J. Weber, Zev J. Gartner · 2017 · Development
31. The BRCT Domains of the BRCA1 and BARD1 Tumor Suppressors Differentially Regulate Homology-Directed Repair and Stalled Fork Protection
    David L. Billing, Michiko Horiguchi, Foon Wu-Baer, Angelo Taglialatela, Giuseppe Leuzzi, Silvia Alvarez Nanez, Wenxia Jiang, Shan Zha, Matthias J. Szabolcs, Chyuan‐Sheng Lin et al. · 2018 · Molecular Cell
32. Single-Cell RNA Sequencing Reveals the Cellular Origin and Evolution of Breast Cancer in BRCA1 Mutation Carriers
    Li Hu, Liming Su, Hainan Cheng, Chunling Mo, Tao Ouyang, Jinfeng Li, Tianfeng Wang, Zhaoqing Fan, Tie Fan, Benyao Lin et al. · 2021 · Cancer Research
33. A NIK-IKKα Module Expands ErbB2-Induced Tumor-Initiating Cells by Stimulating Nuclear Export of p27/Kip1
    Weizhou Zhang, Wei Tan, Xuefeng Wu, Maxim Poustovoitov, Amy Strasner, Wei Li, Nicholas C. Borcherding, Majid Ghassemian, Michael Karin · 2013 · Cancer Cell
34. Molecular characterisation of cell line models for triple-negative breast cancers
    Anita E. Grigoriadis, Alan G. Mackay, Elodie E. Noel, Pei Wu, Rachael Natrajan, Jessica R. Frankum, Jorge Sergio Reis-Filho, Andrew N.J. Tutt · 2012 · BMC Genomics
35. BRCA1 Suppresses Epithelial-to-Mesenchymal Transition and Stem Cell Dedifferentiation during Mammary and Tumor Development
    Feng Bai, Ho Lam Chan, Alexandria Scott, Matthew D. Smith, Cheng Fan, Jason I. Herschkowitz, Charles M. Perou, Alan S. Livingstone, David J. Robbins, Anthony J. Capobianco et al. · 2014 · Cancer Research
36. BRCA1 And Estrogen/Estrogen Receptor In Breast Cancer: Where They Interact?
    Li Wang, Lijun Di · 2014 · International Journal of Biological Sciences
37. Notch Signaling and Breast Cancer
    Michael Reedijk · 2012 · Advances in experimental medicine and biology
38. Breast cancer stem cells
    Thomas W. Owens, Matthew J. Naylor · 2013 · Frontiers in Physiology
39. BRCA1/FANCD2/BRG1-Driven DNA Repair Stabilizes the Differentiation State of Human Mammary Epithelial Cells
    Hua Wang, Brian Bierie, Andrew G. Li, Shailja Pathania, Kimberly J. Toomire, Stoil D. Dimitrov, Ben Liu, Rebecca Sue Gelman, Anita Giobbie‐Hurder, Jean Feunteun et al. · 2016 · Molecular Cell
40. New insights into prostate cancer stem cells
    Xin Chen, Kiera Rycaj, Xin Liu, Dean G. Tang · 2013 · Cell Cycle
41. RANK Signaling Amplifies WNT-Responsive Mammary Progenitors through R-SPONDIN1
    Purna A. Joshi, Paul D. Waterhouse, Nagarajan Kannan, Swami Narala, Hui Fang, Marco A. Di Grappa, Hartland Warren Jackson, Josef Martin Penninger, Connie J. Eaves, Rama Khokha · 2015 · Stem Cell Reports
42. Estrogen Receptor Alpha Mutations in Breast Cancer Cells Cause Gene Expression Changes through Constant Activity and Secondary Effects
    Spencer Arnesen, Zannel Blanchard, Michelle M. Williams, Kristofer C. Berrett, Zheqi Li, Steffi Oesterreich, Jennifer K. Richer, Jason Gertz · 2020 · Cancer Research
43. Single-cell transcriptomics reveals involution mimicry during the specification of the basal breast cancer subtype
    Fátima Valdés‐Mora, Robert Salomon, Brian Gloss, Andrew M. K. Law, Jeron Venhuizen, Lesley E. Castillo, Kendelle Joan Murphy, Astrid Magenau, Michael Papanicolaou, Laura Rodríguez de la Fuente et al. · 2021 · Cell Reports
44. Evidence for accelerated aging in mammary epithelia of women carrying germline BRCA1 or BRCA2 mutations
    Sundus Shalabi, Masaru Miyano, Rosalyn W. Sayaman, Jennifer C. Lopez, Tiina A. Jokela, Michael E. Todhunter, Stefan Hinz, James C. Garbe, Martha R. Stampfer, Kai Kessenbrock et al. · 2021 · Nature Aging
45. ELF5 Suppresses Estrogen Sensitivity and Underpins the Acquisition of Antiestrogen Resistance in Luminal Breast Cancer
    Maria Kalyuga, David Gallego‐Ortega, Heather J Lee, Daniel Lee Roden, Mark J. Cowley, Catherine Elizabeth Caldon, Andrew M. Stone, Stephanie L. Allerdice, Fátima Valdés‐Mora, Rosalind Launchbury et al. · 2012 · PLoS Biology
46. The Omics of Triple-Negative Breast Cancers
    Hong Xu, Peter D. Eirew, Sarah C. Mullaly, Samuel A. J. R. Aparicio · 2013 · Clinical Chemistry
47. Maternal Embryonic Leucine Zipper Kinase Is Upregulated and Required in Mammary Tumor-Initiating Cells In vivo
    Lionel Hebbard, Jochen Maurer, Amber Miller, Jacqueline Lesperance, John A. Hassell, Robert G. Oshima, Alexey V. Terskikh · 2010 · Cancer Research
48. FoxM1 Regulates Mammary Luminal Cell Fate
    Janai R. Carr, Megan M. Kiefer, Hyun Jung Park, Jing Li, Zebin Wang, Joel Fontanarosa, Danielle DeWaal, Dragana Kopanja, Elizaveta V. Benevolenskaya, Grace Guzman et al. · 2012 · Cell Reports
49. Molecular Profiling of Human Mammary Gland Links Breast Cancer Risk to a p27+ Cell Population with Progenitor Characteristics
    Sibgat A. Choudhury, Vanessa Almendro, Vanessa F. Merino, Zhenhua Wu, Reo Maruyama, Ying Su, Filipe Correia Martins, Mary Jo Fackler, Marina Bessarabova, Adam Kowalczyk et al. · 2013 · Cell stem cell
50. P‐Cadherin Is Coexpressed with CD44 and CD49f and Mediates Stem Cell Properties in Basal‐like Breast Cancer
    André Filipe Vieira, Sara Alexandra Vinhas Ricardo, Matthew P. Ablett, Maria Rita Dionísio, Nuno M. Mendes, André Albergaria, Gillian Farnie, Renê Gerhard, José Cameselle‐Teijeiro, Raquel Seruca et al. · 2012 · Stem Cells
51. Choosing a Mouse Model: Experimental Biology in Context--The Utility and Limitations of Mouse Models of Breast Cancer
    Alexander D. Borowsky · 2011 · Cold Spring Harbor Perspectives in Biology
52. Common alleles at 6q25.1 and 1p11.2 are associated with breast cancer risk for BRCA1 and BRCA2 mutation carriers
    Antonis C. Antoniou, Christiana Kartsonaki, Olga M. Sinilnikova, Penny Soucy, Lesley McGuffog, Sue C. Healey, Andrew Lee, Paolo Peterlongo, Siranoush Manoukian, Bernard Peissel et al. · 2011 · Human Molecular Genetics
53. Challenges for Triple Negative Breast Cancer Treatment: Defeating Heterogeneity and Cancer Stemness
    Rinad Mahmoud, Paloma Ordóñez‐Morán, Cinzia Allegrucci · 2022 · Cancers
54. Phenotypic and Molecular Characterization of MCF10DCIS and SUM Breast Cancer Cell Lines
    Nandita Barnabas, Dalia Cohen · 2013 · International Journal of Breast Cancer
55. Runx2 Is a Novel Regulator of Mammary Epithelial Cell Fate in Development and Breast Cancer
    Thomas W. Owens, Renee L. Rogers, Sarah A. Best, Anita Ledger, Anne-Marie Mooney, Alison M. Ferguson, Paul Shore, Alexander Swarbrick, Christopher John Ormandy, Peter T. Simpson et al. · 2014 · Cancer Research
56. Personalized Medicine: The Road Ahead
    Rutika Jitesh Mehta, Rohit Jain, Sunil Badve · 2011 · Clinical Breast Cancer
57. Resistance to Taxanes in Triple-Negative Breast Cancer Associates with the Dynamics of a CD49f+ Tumor-Initiating Population
    Jorge Gomez Miragaya, Marta Palafox, Laia Paré, Guillermo Yoldi, Irene Ferrer, Sergi Vila, Patricia Galván, Pasquale Pellegrini, Héctor Perez‐Montoyo, Ana Igea et al. · 2017 · Stem Cell Reports
58. The Multifaceted Functions of Autophagy in Breast Cancer Development and Treatment
    Nicolas J. Niklaus, Igor Tokarchuk, Mara Zbinden, Anna M. Schläfli, Paola Maycotte, Mario P. Tschan · 2021 · Cells
59. The Met oncogene and basal-like breast cancer: another culprit to watch out for?
    Stefania Gastaldi, Paolo Maria Comoglio, Livio Trusolino · 2010 · Breast Cancer Research
60. Met synergizes with p53 loss to induce mammary tumors that possess features of claudin-low breast cancer
    Jennifer F. Knight, Robert Lesurf, Hong Zhao, Dushanthi Pinnaduwage, Ryan R. Davis, Sadiq M.I. Saleh, Dongmei Zuo, Monica A. Naujokas, Naila Chughtai, Jason I. Herschkowitz et al. · 2013 · Proceedings of the National Academy of Sciences
61. Colorectal Cancer Subtypes: Developmental Origin and Microenvironmental Regulation
    Evelyn Fessler, Jan Paul Medema · 2016 · Trends in cancer
62. Repression of p63 and induction of EMT by mutant Ras in mammary epithelial cells
    Yoh, Kathryn E., Regunath, Kausik, Guzman, Asja, Lee, Seung-Min, Pfister, Neil T., Akanni, Olutosin, Kaufman, Laura J., Prives, Carol, Prywes, Ron · 2016 · Proceedings of the National Academy of Sciences
63. Primitive origins of prostate cancer: In vivo evidence for prostate-regenerating cells and prostate cancer-initiating cells
    Andrew S. Goldstein, Tanya Stoyanova, Owen N. Witte · 2010 · Molecular Oncology
64. Progesterone downregulation of miR-141 contributes to expansion of stem-like breast cancer cells through maintenance of progesterone receptor and Stat5a
    Jessica Finlay-Schultz, Diana M. Cittelly, P Hendricks, P Patel, Peter Kabos, Britta M. Jacobsen, Jennifer K. Richer, Carol A. Sartorius · 2014 · Oncogene
65. BRCA1 regulation of epidermal growth factor receptor (EGFR) expression in human breast cancer cells involves microRNA-146a and is critical for its tumor suppressor function
    Easwari Kumaraswamy, K L Wendt, Laura A. Augustine, Shane Richard Stecklein, E C Sibala, D Li, Sumedha Gunewardena, Roy A. Jensen · 2014 · Oncogene
66. Sustained activation of the HER1–ERK1/2–RSK signaling pathway controls myoepithelial cell fate in human mammary tissue
    Lejla Pasic, T.S. Karin Eisinger‐Mathason, B.T. Velayudhan, Christopher A. Moskaluk, David R. Brenin, Ian G. Macara, Deborah Ann Lannigan · 2011 · Genes & Development
67. Of Mice and Women: A Comparative Tissue Biology Perspective of Breast Stem Cells and Differentiation
    Gabriela Dontu, Tan A. Ince · 2015 · Journal of Mammary Gland Biology and Neoplasia
68. Mechanisms of tumor cell resistance to the current targeted-therapy agents
    G. Khamisipour, Farhad Jadidi-Niaragh, A. S. Jahromi, K. Zandi, M. Hojjat-Farsangi · 2016 · Tumor Biology
69. Estrogen receptor-α signaling in post-natal mammary development and breast cancers
    Mariam Rusidzé, Marine Adlanmérini, Élodie Chantalat, Isabelle Raymond‐Letron, Surya Cayre, Jean‐François Arnal, Marie‐Ange Deugnier, Françoise Lenfant · 2021 · Cellular and Molecular Life Sciences
70. GATA3 functions downstream of BRCA1 to suppress EMT in breast cancer
    Feng Bai, Lihan Zhang, Xiong Liu, Chuying Wang, Chenglong Zheng, Jianping Sun, Min Li, Wei‐Guo Zhu, Xin‐Hai Pei · 2021 · Theranostics
71. DOT1L Is a Novel Cancer Stem Cell Target for Triple-Negative Breast Cancer
    Hetakshi Kurani, Seyedeh Fatemeh Razavipour, Kuzhuvelil B. Harikumar, Matthew Dunworth, Andrew J. Ewald, Apsra Nasir, Gray W. Pearson, Derek Van Booven, Zhiqun Zhou, Diana J. Azzam et al. · 2022 · Clinical Cancer Research
72. Somatic Cell Fusions Reveal Extensive Heterogeneity in Basal-like Breast Cancer
    Ying Su, Ashim Subedee, Noga Bloushtain-Qimron, Virginia Savova, Marcin Krzystanek, Lewyn Li, Andriy Marusyk, Doris P. Tabassum, Alexander Zak, Mary Jo Flacker et al. · 2015 · Cell Reports
73. Cells of origin for cancer: an updated view from prostate cancer
    L. Xin · 2012 · Oncogene
74. The receptor tyrosine kinase ErbB3 maintains the balance between luminal and basal breast epithelium
    Justin Micah Balko, Todd W. Miller, Meghan M. Morrison, Katherine E. Hutchinson, Christian D. Young, Cammie Rinehart, Violeta M. Sanchez, David I.H. Jee, Kornélia Polyák, Aleix Prat et al. · 2011 · Proceedings of the National Academy of Sciences
75. Breast cancer stem cells: Obstacles to therapy
    Matthew John Smalley, Luke Piggott, Richard W. E. Clarkson · 2012 · Cancer Letters
76. Loss of BRCA1 leads to an increase in epidermal growth factor receptor expression in mammary epithelial cells, and epidermal growth factor receptor inhibition prevents estrogen receptor-negative cancers in BRCA1-mutant mice
    Laura N. Burga, Hai Hu, Ashish Juvekar, Nadine Tung, Susan L. Troyan, Erin Wysong Hofstatter, Gerburg M. Wulf · 2011 · Breast Cancer Research
77. A Targetable EGFR-Dependent Tumor-Initiating Program in Breast Cancer
    Paul Savage, Alexis Blanchet-Cohen, Timothée Revil, Dunarel Badescu, Sadiq M.I. Saleh, Yu-Chang Wang, Dongmei Zuo, Leah Liu, Nicholas Bertos, Valentina Muñoz-Ramos et al. · 2017 · Cell Reports
78. Stem and progenitor cell division kinetics during postnatal mouse mammary gland development
    Rajshekhar R. Giraddi, Mona Shehata, Mercedes Gallardo, Marı́a A. Blasco, Benjamin D. Simons, Julia Stingl · 2015 · Nature Communications
79. Evidence of two distinct functionally specialized fibroblast lineages in breast stroma
    Mikkel Morsing, Marie Christine Klitgaard, Abbas Jafari, René Villadsen, Moustapha S Kassem, OLE WILLIAM PETERSEN, Lone Rønnov‐Jessen · 2016 · Breast Cancer Research
80. Molecular apocrine differentiation is a common feature of breast cancer in patients with germline PTEN mutations
    Guillaume Banneau, Mickaël Guedj, Gaëtan Marie MacGrogan, Isabelle de Mascarel, Valérie Velasco, Renaud Schiappa, Valérie Bonadona, Albert David, Catherine Dugast, Brigitte Gilbert‐Dussardier et al. · 2010 · Breast Cancer Research
81. Molecular biology of breast cancer stem cells: Potential clinical applications
    Nam Phong Nguyen, Fabio S. Almeida, Alexander Chi, Ly M. Nguyen, Deirdre Jill Cohen, Ulf Lennart Karlsson, Vincent Vinh‐Hung · 2010 · Cancer Treatment Reviews
82. Disequilibrium of BMP2 Levels in the Breast Stem Cell Niche Launches Epithelial Transformation by Overamplifying BMPR1B Cell Response
    Marion Chapellier, Élodie Bachelard-Cascales, Xenia Schmidt, Flora Clément, Isabelle Treilleux, E. Delay, A Jammot, Christine Ménétrier‐Caux, Gaëtan Pochon, Roger Besançon et al. · 2015 · Stem Cell Reports
83. Quantitative single cell analysis of cell population dynamics during submandibular salivary gland development and differentiation
    Deirdre A. Nelson, Charles T. Manhardt, Vidya P. Kamath, Yunxia Sui, Alberto Santamaría-Pang, Ali Can, Musodiq O. Bello, Alex D. Corwin, Sean R. Dinn, Michael Lazare et al. · 2013 · Biology Open
84. Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth
    Keren Weidenfeld, Sagie Schif‐Zuck, Hanan Abu-Tayeh, Keunsoo Kang, Ofra Kessler, Marina Weissmann, Gera Neufeld, Dalit Barkan · 2016 · Oncotarget
85. Mammary-Stem-Cell-Based Somatic Mouse Models Reveal Breast Cancer Drivers Causing Cell Fate Dysregulation
    Zheng Zhang, John R. Christin, Chunhui Wang, Kai Ge, Maja H. Oktay, Wenjun Guo · 2016 · Cell Reports
86. In Vitro Analysis of Breast Cancer Cell Line Tumourspheres and Primary Human Breast Epithelia Mammospheres Demonstrates Inter- and Intrasphere Heterogeneity
    Chanel Elisha Smart, Brian J. Morrison, Jodi M. Saunus, Ana Cristina Vargas, Patricia Keith, Lynne Reid, Leesa F. Wockner, Marjan Askarian-Amiri, Debina Sarkar, Peter T. Simpson et al. · 2013 · PLoS ONE
87. How many diseases is triple negative breast cancer: the protagonism of the immune microenvironment
    Diana P. Saraiva, Maria Guadalupe Cabral, António Jacinto, Sofia Azambuja Braga · 2017 · ESMO Open
88. The roots of cancer: Stem cells and the basis for tumor heterogeneity
    Maho Shibata, Michael M. Shen · 2012 · BioEssays
89. Biology of breast cancer during pregnancy using genomic profiling
    Hamdy A. Azim, Sylvain Brohée, Fedro Alessandro Peccatori, Christine Desmedt, Sherene Loi, Diether Lambrechts, Patrizia Dell’Orto, Samira Majjaj, Vinu José, Nicole Rotmensz et al. · 2014 · Endocrine Related Cancer
90. A novel molecular mechanism involved in multiple myeloma development revealed by targeting MafB to haematopoietic progenitors
    Carolina Vicente‐Dueñas, Isabel Romero-Camarero, Inés González‐Herrero, Esther Alonso-Escudero, Fernando Abollo‐Jiménez, Xiaoyu Jiang, Norma Carmen Gutierrez, Alberto Órfão, Nieves Marín, Luisa María Villar et al. · 2012 · The EMBO Journal
91. Stem Cell Determinant SOX9 Promotes Lineage Plasticity and Progression in Basal-like Breast Cancer
    John R. Christin, Chunhui Wang, Chi‐Yeh Chung, Yu Liu, Christopher Dravis, Wei Tang, Maja H. Oktay, Geoffrey M. Wahl, Wenjun Guo · 2020 · Cell Reports
92. Loss of XIST Impairs Human Mammary Stem Cell Differentiation and Increases Tumorigenicity Through Enhancer and Mediator Complex Hyperactivation
    Laia Richart, Mary-Loup Picod-Chedotel, Michel Adam Wassef, Manon Macario, Setareh Aflaki, Marion A. Salvador, Tiphaine Héry, Aurélien Dauphin, Julien Wicinski, Véronique Chevrier et al. · 2021 · Cell
93. ER-α36-Mediated Rapid Estrogen Signaling Positively Regulates ER-Positive Breast Cancer Stem/Progenitor Cells
    Hao Deng, Xintian Zhang, Μolin Wang, Hongyan Zheng, Lìjiāng Liú, Zhaoyi Wang · 2014 · PLoS ONE
94. Clonal Analysis via Barcoding Reveals Diverse Growth and Differentiation of Transplanted Mouse and Human Mammary Stem Cells
    Long V. Nguyen, Maisam Makarem, Annaïck Carles, Michelle Moksa, Nagarajan Kannan, Pawan K. Pandoh, Peter D. Eirew, Tomo Osako, Melanie Kardel, Alice Man Sze Cheung et al. · 2014 · Cell stem cell
95. The Role of Proliferation in Determining Response to Neoadjuvant Chemotherapy in Breast Cancer: A Gene Expression–Based Meta-Analysis
    Daniel G. Stover, Jonathan L. Coloff, William Thomas Barry, Joan S. Brugge, Eric P. Winer, Laura M. Selfors · 2016 · Clinical Cancer Research
96. Heterogeneity and Plasticity of Breast Cancer Stem Cells
    Bárbara Sousa, Ana Sofia Ribeiro, Joana Paredes · 2019 · Advances in experimental medicine and biology
97. EMT in breast cancer stem cell generation
    Stéphane Ansieau · 2012 · Cancer Letters
98. Methylation profiling of 48 candidate genes in tumor and matched normal tissues from breast cancer patients
    Zibo Li, Xinwu Guo, Yepeng Wu, Shengyun Li, Jinhua Yan, Limin Peng, Zhi Qiang Xiao, Shouman Wang, Zhongping Deng, Lizhong Dai et al. · 2015 · Breast Cancer Research and Treatment
99. Immortalization of normal human mammary epithelial cells in two steps by direct targeting of senescence barriers does not require gross genomic alterations
    James C. Garbe, Lukáš Vrba, Klara Sputova, Laura Fuchs, Petr Novák, Arthur R. Brothman, Mark W. Jackson, Koei Chin, Mark A. LaBarge, George S. Watts et al. · 2014 · Cell Cycle
100. Stem cells in normal development and cancer.
     R. D'Angelo, M. Wicha · 2010 · Progress in Molecular Biology and Translational Science